Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling.

Zhou, Ji; Peng, Yang; Gao, Ying-Chun; Chen, Tai-Yu; Li, Peng-Cheng; Xu, Ke; Liu, Tao; Ren, Tao.

Afiliação

Zhou J; Health Management Centre, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, 278 Baoguang St, Xindu Distr, Chengdu, 610500, Sichuan, China.
Peng Y; Hematology Department, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, China.
Gao YC; Oncology Department, Pengzhou People's Hospital, Chengdu, 611900, China.
Chen TY; Clinical Medical College of Chengdu Medical College, Chengdu, 610500, China.
Li PC; Oncology Department, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, 278 Baoguang St, XinduDistr, Chengdu, 610500, Sichuan, China.
Xu K; Oncology Department, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, 278 Baoguang St, XinduDistr, Chengdu, 610500, Sichuan, China.
Liu T; Oncology Department, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, 278 Baoguang St, XinduDistr, Chengdu, 610500, Sichuan, China.
Ren T; Oncology Department, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, 278 Baoguang St, XinduDistr, Chengdu, 610500, Sichuan, China. rentao509@cmc.edu.cn.

Cancer Cell Int ; 21(1): 338, 2021 Jul 03.

Article em En | MEDLINE | ID: mdl-34217321